Cargando…
Anti-angiogenic activity of ShengMaBieJia decoction in vitro and in acute myeloid leukaemia tumour-bearing mouse models
CONTEXT: ShengMaBieJia decoction (SMBJD) is used to treat solid and hematological tumours; however, its anti-angiogenesis activity remains unclear. OBJECTIVE: This study verified the anti-angiogenic effects of SMBJD in vitro and in tumour-bearing acute myeloid leukaemia (AML) mouse models. MATERIALS...
Autores principales: | Wang, Mengya, Ma, Bangyun, Dai, Xingbin, Zhang, Hong, Dai, Huibo, Wang, Jingyu, Liu, Li, Sun, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7301716/ https://www.ncbi.nlm.nih.gov/pubmed/32432951 http://dx.doi.org/10.1080/13880209.2020.1764059 |
Ejemplares similares
-
A Systems Biology-Based Investigation into the Pharmacological Mechanisms of Sheng-ma-bie-jia-tang Acting on Systemic Lupus Erythematosus by Multi-Level Data Integration
por: Huang, Lin, et al.
Publicado: (2015) -
Shengma Biejia Decoction Inhibits Cell Growth in Multiple Myeloma by Inducing Autophagy-Mediated Apoptosis Through the ERK/mTOR Pathway
por: Dai, Huibo, et al.
Publicado: (2021) -
Cimigenol depresses acute myeloid leukemia cells protected by breaking bone marrow stromal cells via CXCR4/SDF‑1α
por: Ma, Bangyun, et al.
Publicado: (2022) -
Bie Jia Jian pill enhances the amelioration of bone mesenchymal stem cells on hepatocellular carcinoma progression
por: Jingjing, Huang, et al.
Publicado: (2021) -
Solasonine Suppresses the Proliferation of Acute Monocytic Leukemia Through the Activation of the AMPK/FOXO3A Axis
por: Zhang, Hong, et al.
Publicado: (2021)